
Regencell Bioscience
(NASDAQ) RGC
Regencell Bioscience Financials at a Glance
Market Cap
$9.90B
Revenue (TTM)
$0.00
Net Income (TTM)
-$8.90M
EPS (TTM)
-$0.01
P/E Ratio
-1407.75
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$20.07
Volume
101,882.672
Open
$22.50
Price
$20.07
Volume
101,882.672
Open
$22.50
Previous Close
$19.99
Daily Range
$19.70 - $22.50
52-Week Range
$9.39 - $83.60
Estimated Earnings Date
Jun 5, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$20.07
Volume
101,882.672
Open
$22.50
Previous Close
$19.99
Daily Range
$19.70 - $22.50
52-Week Range
$9.39 - $83.60
Estimated Earnings Date
Jun 5, 2026
RGC News



RGC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Regencell Bioscience
Industry
Pharmaceuticals
Sector
Health CareEmployees
10
CEO
Yat-Gai Au
Website
www.regencellbioscience.comHeadquarters
Causeway Bay, KY1-1107, HK
RGC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-178%
Return on Capital
-5%
Return on Assets
-2%
Earnings Yield
-0.07%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.90B
Shares Outstanding
495.47M
Volume
101.88K
Avg. Volume
132.11K
Financials (TTM)
Gross Profit
-$392.74K
Operating Income
-$3.77M
EBITDA
-$3.19M
Operating Cash Flow
-$3.11M
Capital Expenditure
-$152.69K
Free Cash Flow
-$3.27M
Cash & ST Invst.
$4.90M
Total Debt
$544.42K
Regencell Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$40.84K
N/A
Gross Margin
0.00%
N/A
Market Cap
$9.90B
N/A
Market Cap/Employee
$825.38M
N/A
Employees
12
N/A
Net Income
-$5.32M
-514555.0%
EBITDA
-$5.30M
-358.5%
Quarterly Fundamentals
Net Cash
$1.97M
-58.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$128.18K
N/A
Short Term Debt
$258.12K
N/A
Return on Assets
-2.34%
N/A
Return on Invested Capital
-5.29%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$0.00
+100.0%
